What Could be the Harm? Minnesota's Harmless Error Statute
Against the backdrop of a global pandemic, many clients developed a newfound sense of urgency regarding their estate planning, which presented new challenges in light of the attendant health risks and...
View ArticleThe Brave New World of Virtual Notarization
The COVID-19 pandemic and consequent state and federal guidelines forced people to work from home before they were able to take steps so that they could do so effectively. This new working dynamic...
View ArticleVol. 5, No. 2
We hope that you and your loved ones are staying safe and healthy as we all continue to learn and reimagine our lives and communities. As we do so, we pleased to offer the latest edition of The Robins...
View ArticleAmgen Inc. v. Amneal Pharms. LLC
Case Name: Amgen Inc. v. Amneal Pharms. LLC, No. 16-853-MSG (consol.), 2019 U.S. Dist. LEXIS 159358 (D. Del. Sept. 19, 2019) (Goldberg, J.) Drug Product and Patent(s)-in-Suit: Sensipar® (cinacalcet HCl...
View ArticleIndivior Inc. v. Dr. Reddy’s Labs., S.A.
Case Name: Indivior Inc. v. Dr. Reddy’s Labs., S.A., No. 2017-2587, 2018-1010, -1058, -1062, -1114, -1115, -1176, -1177, -1949, -2045, 2019 U.S. App. LEXIS 20680 (Fed. Cir. July 12, 2019) (Circuit...
View ArticleEli Lilly and Co. v. Hospira, Inc.
Case Name: Eli Lilly and Co. v. Hospira, Inc., Nos. 2018-2126, -2127, 2128, 2019 U.S. App. LEXIS 23753 (Fed. Cir. Aug. 9, 2019) (Circuit Judges Lourie, Moore, and Taranto presiding; Opinion by Lourie,...
View ArticleSanofi-Aventis U.S., LLC v. Dr. Reddy’s Labs., Inc.
Case Name: Sanofi-Aventis U.S., LLC v. Dr. Reddy’s Labs., Inc., No. 2018-1804, 2019 U.S. App. LEXIS 24141 (Fed. Cir. Aug. 14, 2019) (Circuit Judges Lourie, Moore, and Taranto presiding; Opinion by...
View ArticleNalpropion Pharms., Inc. v. Actavis Labs. FL, Inc.
Case Name: Nalpropion Pharms., Inc. v. Actavis Labs. FL, Inc., 934 F.3d 1344 (Fed. Cir. Aug. 15, 2019) (Circuit Judges Prost, Lourie, and Wallach presiding; Opinion by Lourie, J.; Dissent-in-part by...
View ArticleINO Therapeutics LLC v. Praxair Distribution Inc.
Case Name: INO Therapeutics LLC v. Praxair Distribution Inc., 2019 U.S. App. LEXIS 25756 (Fed. Cir. Aug. 27, 2019) (Circuit Judges Prost, Newman, and Dyk presiding; Opinion by Prost, C.J.; Dissenting...
View ArticleAllergan Sales, LLC v. Sandoz, Inc
Case Name: Allergan Sales, LLC v. Sandoz, Inc., No. 2018-2207, 2019 U.S. App. LEXIS 26200 (Fed. Cir. Aug. 29, 2019) (Circuit Judges Prost, Newman, and Wallach presiding; Opinion by Wallach, J.;...
View Article“That Settles It”: The Georgia Supreme Court Provides Clarity Regarding an...
The issue of whether an insurer has fulfilled its duty to settle in good faith was recently litigated in Georgia. Under Georgia law “[a]n insurance company may be liable for the excess judgment entered...
View ArticleHot off the Presses: California Further Regulates Out-of-State Adjusters in...
Over the past few years, California has endured some of the largest catastrophic losses in the state’s history. For example, in July 2018, the Mendocino Complex Fire consumed almost 460,000 acres of...
View ArticleEmpire State of Mind: New York Bad Faith Update
It is well settled that, in New York, there can be no separate tort cause of action for an insurer’s purported bad faith failure to perform its obligations under an insurance contract. In the...
View ArticleArtificial Intelligence v. General Data Protection Regulation: Complex Risks...
Artificial Intelligence (“AI”) swallows vast troves of data, so, as its definition suggests, it enables “the capability of a machine to imitate intelligent human behavior.”1 Much like humans learn over...
View Article2019 Case Developments: Are Massachusetts Insurers Required To Be Perfect In...
“[E]very case has its twists and turns and an insurance carrier is not to be held to a duty of prescience.”1In Massachusetts, General Laws Chapter 176D (“Ch. 176D”) prohibits insurance carriers from...
View ArticleCelgene Corp. v. Sun Pharma Global FZE
Case Name: Celgene Corp. v. Sun Pharma Global FZE, No. 19-10099 (SDW) (LDW), 2020 WL 1921700 (D.N.J. Apr. 6, 2020) (Wigenton, J.) Drug Product and Patent(s)-in-Suit: Revlimid® (lenalidomide); U.S....
View ArticleValeant Pharms Int’l, Inc. v. Mylan Pharms Inc.
Case Name: Valeant Pharms Int’l, Inc. v. Mylan Pharms Inc., No. 2018-2097, 2020 WL 1698591 (Fed. Cir. April 8, 2020) (Circuit Judges Lourie, Reyna, and Hughes presiding; Opinion by Lourie, J.) (Appeal...
View ArticleSomaxon Pharma, Inc. v. Actavis Elizabeth LLC
Case Name: Somaxon Pharma, Inc. v. Actavis Elizabeth LLC, No. 10-1100, 2020 WL 1903171 (D. Del. April 9, 2020) (Fallon, J.)Drug Product and Patent(s)-in-Suit: Silenor® (doxepin hydrochloride); U.S....
View ArticleBiogen Int'l GmbH v. Banner Life Scis. LLC
Case Name: Biogen Int'l GmbH v. Banner Life Scis. LLC, 956 F.3d 1351 (Fed. Cir. April 21, 2020)(Circuit Judges Lourie, Moore, and Chen presiding; Opinion by Lourie, J.) (Appeal from D. Del., Stark, J.)...
View ArticleCephalon, Inc. v. Slayback Pharma Ltd.
Case Name: Cephalon, Inc. v. Slayback Pharma Ltd., No. 17-1154-CFC, 2020 WL 1983730 (D. Del. April 27, 2020) (Connolly, J.) Drug Product and Patent(s)-in-Suit: Bendeka® (bendamustine hydrochloride);...
View Article